{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T19:45:54Z","timestamp":1704311154363},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/01.phh.0000267684.23529.2c","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T13:37:08Z","timestamp":1377783428000},"page":"263-269","source":"Crossref","is-referenced-by-count":7,"title":["Benefits and Adverse Effects of Hepatitis C Screening"],"prefix":"10.1097","volume":"13","author":[{"given":"Mary Jo","family":"Trepka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fermin","family":"Leguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Obiaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Malow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"De La Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-6-20210210","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"issue":"RR-19","key":"R3-6-20210210","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.","volume":"47","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-6-20210210","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/archinte.161.18.2231","article-title":"Costs of hepatitis C.","volume":"161","author":"Leigh","year":"2001","journal-title":"Arch Intern Med"},{"issue":"1","key":"R5-6-20210210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2000-9505","article-title":"Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.","volume":"20","author":"Alter","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"3","key":"R6-6-20210210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.amepre.2004.12.009","article-title":"Screening for chronic hepatitis C: American College of Preventive Medicine practice policy statement.","volume":"28","author":"Hill","year":"2005","journal-title":"Am J Prev Med"},{"issue":"suppl 3","key":"R7-6-20210210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the U.S. preventive services task force: a review of the process.","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"R8-6-20210210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"R9-6-20210210","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial.","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"R10-6-20210210","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-140-6-200403160-00014","article-title":"Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventative Services Task Force.","volume":"140","author":"Chou","year":"2004","journal-title":"Ann Intern Med"},{"issue":"3","key":"R11-6-20210210","first-page":"1","article-title":"Consensus Conference Statement. Management of hepatitis C: 2002.","volume":"19","year":"2002","journal-title":""},{"key":"R12-6-20210210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.7326\/0003-4819-140-6-200403160-00013","article-title":"Screening for hepatitis C in adults.","volume":"140","year":"2004","journal-title":"Ann Intern Med"},{"key":"R13-6-20210210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.510310332","article-title":"The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.","volume":"31","author":"Armstrong","year":"2000","journal-title":"Hepatology"},{"key":"R14-6-20210210","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199801293380503","article-title":"Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.","volume":"338","author":"Vento","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"R15-6-20210210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00004836-200107000-00006","article-title":"Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.","volume":"33","author":"Koff","year":"2001","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"R16-6-20210210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-8278(98)80198-0","article-title":"Characteristics of patients with dual infection by hepatitis B and C viruses.","volume":"29","author":"Zarski","year":"1998","journal-title":"J Hepatol"},{"issue":"RR-6","key":"R17-6-20210210","first-page":"61","article-title":"Sexually transmitted diseases treatment guidelines 2002.","volume":"51","author":"Workowski","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"R18-6-20210210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5993\/AJHB.29.6.6","article-title":"Behavior modification following a diagnosis of hepatitis C infection.","volume":"29","author":"Lindsey","year":"2005","journal-title":"Am J Health Behav"},{"issue":"3","key":"R19-6-20210210","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2004-832942","article-title":"Alcohol and hepatitis C.","volume":"24","author":"Safdar","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"2","key":"R20-6-20210210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0168-8278(01)00114-3","article-title":"Impact of medical recommendations on alcohol consumption in HCV positive patients.","volume":"35","author":"Nalpas","year":"2001","journal-title":"J Hepatol"},{"key":"R21-6-20210210","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1467-842X.1998.tb01423.x","article-title":"Hepatitis C virus infection: impacts on behaviour and lifestyle.","volume":"22","author":"Sladden","year":"1998","journal-title":"Aust N Z J Public Health"},{"key":"R22-6-20210210","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/342063","article-title":"Lack of behavior change after disclosure of hepatitis C virus infection among injection drug users in Baltimore, Maryland.","volume":"35","author":"Ompad","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R23-6-20210210","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2002.00208.x","article-title":"The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.","volume":"97","author":"Kwiatkowski","year":"2002","journal-title":"Addiction"},{"key":"R24-6-20210210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1007622831518","article-title":"HCV status knowledge and risk behaviours amongst intravenous drug users.","volume":"16","author":"Vidal-Trecan","year":"2000","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"R25-6-20210210","first-page":"S93","article-title":"Prevention of spread of hepatitis C.","volume":"36","author":"Alter","year":"2002","journal-title":"Hepatology"}],"container-title":["Journal of Public Health Management and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.PHH.0000267684.23529.2c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:37:56Z","timestamp":1620934676000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124784-200705000-00006"}},"subtitle":["Early Results of a Screening Program"],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.phh.0000267684.23529.2c","relation":{},"ISSN":["1078-4659"],"issn-type":[{"value":"1078-4659","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}